Netherlands· NL-7a404998a74c
Cetirmar 5 mg tabletten
A levocetirizine product containing levocetirizinedihydrochloride, registered in Netherlands by Synthon B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Levocetirizine is registered in 16 of 19 countries.
Countries holding a registration under ATC R06AE09 (levocetirizine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Levocetirizine · ATC R06AE09
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levocetirizine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.15 in France to $0.53 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levocetirizine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- ES Spain$0.34
- IT Italy$0.21
- FR France$0.15
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LEVOCETIRIZINEDIHYDROCHLORIDE
- Manufacturer
- Synthon B.V.
- Country
- Netherlands (NL)
- ATC code
- R06AE09
- ATC class
- Levocetirizine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id101135
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
267 interactions on record for levocetirizine.
Graded by severity as the source publishes them — 264 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levocetirizine · interactions on record
267 records
- 264 moderate
- 3 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levocetirizine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- PolandAlcetyrArtespharm Sp. z o.o.
- United Statesallergy reliefRite Aid Corporation
- SpainARALEVO 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGArafarma Group S.A.
- ItalyLEVOCETIRIZINA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- FinlandAltoralUCB Pharma Oy Finland
- SwitzerlandLevocetirizin Sandoz 5mg, FilmtablettenSandoz Pharmaceuticals AG
- FranceLEVOCETIRIZINE ARROW 5 mg, comprimé pelliculéARROW GENERIQUES
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Lecisyn, Lecivriens
- Belgium · Levocetirizin Ab, Levocetirizine Eg
- Bulgaria · Алерцит, Зенаро
- Cyprus · Ebrilon, Xyzal
- Czechia · Alergimed, Analergin Neo
- Germany · Levoceti Abz, Levocetirizin 1 A Pharma
- Denmark · Levocetirizin Glenmark, Levocetirizin Krka
- Estonia · Cezera, Lewojet
- Spain · Aralevo, Levocetirizina Aurovitas Spain
- Finland · Levocetirizin Ratiopharm, Levocetirizin Stada
- France · Levocetirizine Arrow, Levocetirizine Biogaran
- United Kingdom (Northern Ireland) · Levocetirizina Activase, Levocetirizine
- Greece · Contrahist, Levocet
- Croatia · Xyzal
- Hungary · Cezera, Histisynt
- Ireland · Levocetirizine Dihydrochloride Brillpharma (Ireland), Levocetirizine Glenmark
- Italy · Levocetirizina Aurobindo, Levocetirizina Doc Generici
- Lithuania · Cezera, Xyzal
- Luxembourg · Levocetirizine Eg, Xyzall
- Latvia · Xyzal
- Malta · Rinozal, Xyzal
- Norway · Xyzal
- Poland · Alergimed, Allefin Allergy
- Portugal · Dicloridrato De Levocetirizina Ratiopharm, Levocetirizina
- Romania · Cezera, Levocetirizină Terapia
- Slovenia · Cezera, Xyzal
- Slovakia · Alergimed, Cezera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cb7beee-4aff-4199-bd33-6462eefb60c6 GET /v1/drugs/5cb7beee-4aff-4199-bd33-6462eefb60c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h101135_smpc.pdf",
"strength": null,
"atc_label": "Levocetirizine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg101135",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"HYPROMELLOSE (E 464)",
"LACTOSE 1-WATER",
"MACROGOL 400",
"MAGNESIUMSTEARAAT (E 470b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"LEVOCETIRIZINEDIHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h101135.pdf",
"authorised_at": "2010/01/29",
"procedure_number": "NL/H/4806/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "101135",
"additional_monitoring": "N"
}See everything about levocetirizine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.